Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive analysis of volatile compounds in cold-pressed safflower seed oil from Xinjiang, China.

Food science & nutrition·2020
Same author

Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer.

Cancer communications (London, England)·2020
Same author

Murine and Human Cathelicidins Contribute Differently to Hallmarks of Mastitis Induced by Pathogenic <i>Prototheca bovis</i> Algae.

Frontiers in cellular and infection microbiology·2020
Same author

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.

Journal of hematology & oncology·2020
Same author

Autophagy of bovine mammary epithelial cell induced by intracellular Staphylococcus aureus.

Journal of microbiology (Seoul, Korea)·2020
Same author

The Phosphodiesterase-5 Inhibitor Vardenafil Improves the Activation of BMP Signaling in Response to Hydrogen Peroxide.

Cardiovascular drugs and therapy·2020
Same journal

Acute pneumopericardium: when echocardiography is not enough.

Acute cardiac care·2018
Same journal

Mayo registry for telemetry efficacy in arrest study: An evaluation of the feasibility of the do not intubate code status.

Acute cardiac care·2017
Same journal

A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department.

Acute cardiac care·2017
Same journal

Demographic and clinical features of atrial myxomas: A case series analysis.

Acute cardiac care·2017
Same journal

Pregnant women with heart disease: Placental characteristics and their association with fetal adverse events.

Acute cardiac care·2017
Same journal

Double guide double wrist 5F left coronary artery transradial percutaneous coronary intervention and the X-Kiss technique.

Acute cardiac care·2017
See all related articles

Related Experiment Videos

Loss of systemic endothelial function post-PCI.

Bo Han1, Diab Ghanim, Aviva Peleg

  • 1The Cardiovascular Institute, The Baruch Padeh Medical Center, Lower Galilee, Israel.

Acute Cardiac Care
|June 24, 2008
PubMed
Summary
This summary is machine-generated.

Loss of endothelial function after PCI is common. Nesiritide, a form of BNP, significantly improved blood vessel function and reduced harmful endothelin levels in patients experiencing this complication.

Related Experiment Videos

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Interventional Cardiology

Background:

  • Loss of endothelial function (LEF) following percutaneous coronary intervention (PCI) can lead to adverse outcomes.
  • Brain natriuretic peptide (BNP) has shown potential protective effects on the endothelium.
  • Impaired ProBNP cleavage to BNP may be linked to post-PCI LEF.

Purpose of the Study:

  • To investigate the effect of nesiritide, a recombinant human BNP, on endothelial function post-PCI.
  • To explore the relationship between plasma levels of corin, BNP, ProBNP, and endothelin in patients undergoing PCI.

Main Methods:

  • Measured flow-mediated vasodilation (FMD) and plasma levels of endothelin, BNP, ProBNP, and corin before and after PCI in 49 patients.
  • Randomized 30 patients who developed LEF post-PCI to receive either intravenous nesiritide or saline infusion for 3 hours.

Main Results:

  • Patients developing LEF post-PCI had lower baseline corin levels and a reduced BNP/ProBNP ratio post-procedure.
  • Nesiritide infusion significantly improved FMD immediately and 24 hours post-treatment compared to saline.
  • Nesiritide reduced elevated plasma endothelin-1 levels, while saline did not.

Conclusions:

  • Systemic LEF is a frequent occurrence after PCI, potentially linked to impaired ProBNP processing.
  • Short-term intravenous nesiritide administration effectively improves endothelial function post-PCI.
  • Nesiritide demonstrates a therapeutic benefit in mitigating post-PCI endothelial dysfunction.